Center For Neurologic Study

Organization Overview

Center For Neurologic Study is located in La Jolla, CA. The organization was established in 1990. According to its NTEE Classification (G96) the organization is classified as: Neurology & Neuroscience, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2021, Center For Neurologic Study employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Center For Neurologic Study is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 06/2021, Center For Neurologic Study generated $2.0m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (38.3%) each year. All expenses for the organization totaled $531.2k during the year ending 06/2021. As we would expect to see with falling revenues, expenses have declined by (40.5%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.

Since 2017, Center For Neurologic Study has awarded 12 individual grants totaling $715,179. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990 Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

TO ADVANCE THE CAUSE OF PATIENTS WITH DISORDERS OF THE NERVOUS SYSTEM.

Describe the Organization's Program Activity:

Part 3 - Line 4a

RESEARCH: WORK UNDERTAKEN AT CNS PLAYED A ROLE IN THE INTRODUCTION OF INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS. THE CENTER PARTICIPATED IN NUMEROUS NATIONAL, EXPERIMENTAL TREATMENT TRIALS INVOLVING AMYOTROPHIC LATERAL SCLEROSIS, ALZHEIMER'S DISEASE, NEUROPATHY WHICH LED TO THE DISCOVERY OF NUEDEXTA WHICH HAS BEEN APPROVED FOR USE IN THE UNITED STATES AND EUROPE. REMARKABLY, THE DRUG HAS IMPROVED FUNCTION IN BOTH ALZHEIMER'S DISEASE AND ALS PATIENTS, WITH STUDY RESULTS PUBLISHED IN MAJOR SCIENTIFIC JOURNALS. PIONEERING WORK DONE AT CNS IN COLLABORATION WITH THE UNIVERSITY OF CALIFORNIA AND IONIS PHARMACEUTICALS IS WIDELY BELIVED TO BE THE MOST PROMISING STRATEGY FOR TREATING NEURODEGENERATIVE DISEASES SUCH AS HUNTINGTON'S DISEASE AND FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS. THIS STRATEGY INVOLVES THE SYNTHESIS OF SMALL MOLECULES THAT DOWN REGULATE THE EXPRESSION OF MUTANT PROTEINS IN THE BRAIN. THE LATTER RESULTS WERE PRESENTED AT THE 2018 ANNUAL MEETING OF THE AMERICAN ACADEMY OF NEUROLOGY.


PUBLIC EDUCATION: RESEARCH CONDUCTED AT CNS HAS BEEN PRESENTED PUBLICALLY AT MEDICAL AND SCIENTIFIC MEETINGS AND PUBLISHED IN LEADING SCIENTIFIC JOURNALS. THESE ACTIVITIES HAVE BEEN REPORTED UPON IN LOCAL AND NATIONAL MEDIA, INCLUDING NBC AND CNN TELEVISION, THE SAN DIEGO UNION TRIBUNE, THE LOS ANGELES AND NEW YORK TIMES AND SCIENTIFIC AMERICAN. CNS ALSO PROVIDES INFORMATION ABOUT NEUROLOGICAL DISEASES TO PATIENTS, PHYSICIANS AND THE GENERAL PUBLIC VIA IT'S WEBSITE (CNSONLINE.ORG). ADDITIONALY CNS IS INVOLVED IN ORGANIZING AN ANNUAL CONFERENCE ON AMYOTROPHIC LATERAL SCLEROSIS IN COLLABORATION WITH ACADEMIC INSTITUTUIONS IN CALIFORNIA (CALIFORNIA ALS SUMMIT).


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Board, Officers & Key Employees

Name (title)Compensation
Richard A Smith MD
President
$100,000
Kathleen Myers
Secretary/treas
$48,000
Randall Kaye MD
Director
$0
Steve Bordner
Director
$0
David Louis Cutchin PHD
Director
$0
Cherryl Goldstwin
Director
$0

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$44
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$44
Total Program Service Revenue$0
Investment income $442,759
Tax Exempt Bond Proceeds $0
Royalties $50,000
Net Rental Income $0
Net Gain/Loss on Asset Sales $1,495,487
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $1,988,290

Grants Awarded

Over the last fiscal year, Center For Neurologic Study has awarded $65,000 in support to 2 organizations.

Grant RecipientAmount

UC SAN DIEGO FOUNDATION

Org PageRecipient Profile

La Jolla, CA

PURPOSE: SUPPORT ALS /JOHN RAVIT'S RESEARCH

$50,000

THE ALS ASSOC - GW CHAPTER

Org PageRecipient Profile

Woodland Hills, CA

PURPOSE: SUPPORT ALS RESEARCH

$15,000
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 1 grants that Center For Neurologic Study has recieved totaling $63.

Awarding OrganizationAmount
Amazonsmile Foundation

Seattle, WA

PURPOSE: GENERAL SUPPORT

$63
View Grant Recipient Profile

Create an account to unlock the data you need.

or